[1]
A. Sagdeo, M. Elshehawy, C. Rakieh, P. Ball, and H. Morrissey, “Severe hypocalcaemia and hypophosphatemia following Denosumab administration in a multi-comorbidity patient”, Medicine and Pharmacy Reports, Sep. 2024.